CREATION Health Readmission Risk Assessment Tool

This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrument refinement. Phase 2 involves administering the refined instrument to a new group of patients to determine final item content for the instrument, its factor structure, and its predictive validity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Brain Diseases COPD Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Chronic Disease Coronary Artery Bypass Graft Disease Attributes Heart Diseases Infarction Infections Ischemia Lung Diseases Lung Diseases, Obstructive Myocardial Infarction Myocardial Ischemia Necrosis Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Respiratory Tract Infections Stroke Total Hip Replacement Total Knee Replacement Vascular Diseases

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Florida Hospital

Orlando, Florida, 32804, United States

About this study

Participants will complete the instrument on an electronic device provided by research staff in the hospital room. If an individual is unable to complete the instrument, the participant may have another individual input answers on the electronic device. Hospitalized patients (n = 1240: 620 in Phase 1 and 620 in Phase 2) with a variety of chronic diseases will be recruited into the study. Study coordinators will recruit participants with the following diagnoses: heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, coronary artery bypass graft, pneumonia, total knee or hip replacement, and stroke. These diagnoses were chosen because of the frequency with which patients are readmitted after discharge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Primary or secondary admission diagnosis of heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, coronary artery bypass graft, pneumonia, total knee or hip replacement, or stroke.
Age 21 and over
Able to provide informed consent
Able to speak and read English
Able to complete an electronic survey or relay answers to questions to another party who may complete the survey for the participant
Resides in Central Florida and anticipates continued residence in Central Florida for the next 120 days
Planned discharge to a non-hospital or residential care environment

Exclusion criteria

Under age 21
Does not speak or read English
Permanent residence is outside Central Florida
Not of cognitive capacity to provide valid responses
Dementia or cognitive impairment that renders subject unable to provide informed consent
Prescribed a known psychoactive medication that might reasonably affect the ability of the participant to provide valid responses

Treatment and study plan

Primary outcomes

Social Determinant Survey Responses

Time frame: 24 Months

An Investigator developed measurement instrument (survey) will be used to gather participant self reported responses to questions regarding spirituality, nutrition, sleep, activity level, interpersonal relationships, home environment and access to transportation. Participants will be provided a five point Likert Scale to express agreement or disagreement with the questions.

Secondary outcomes

Readmission Status

Time frame: 24 Months

Data extraction from each participant's medical record will be used to determine the number of readmissions within 120 days post discharge.

Sponsors and collaborators

Lead sponsor

AdventHealth

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2019
First posted: Feb 7, 2018
Registry last updated: Feb 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed